---
title: "上海康耐特光学通过私募配售筹集了 14 亿港元"
description: "上海康耐特光学有限公司通过私募发行 2700 万股新股，筹集了 14 亿港元，每股定价为 52.00 港元，目标至少六位独立投资者。该发行未在美国证券法下注册，且不向美国投资者提供。筹集的资金将用于支持未来的业务发展"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/273752657.md"
published_at: "2026-01-26T22:06:38.000Z"
---

# 上海康耐特光学通过私募配售筹集了 14 亿港元

> 上海康耐特光学有限公司通过私募发行 2700 万股新股，筹集了 14 亿港元，每股定价为 52.00 港元，目标至少六位独立投资者。该发行未在美国证券法下注册，且不向美国投资者提供。筹集的资金将用于支持未来的业务发展

上海康耐特光学有限公司宣布通过私募配售方式在一般授权下发行 2700 万股新股。这些股票将以每股 52.00 港元的配售价格提供给至少六位独立投资者。公司强调，此次发行未在美国 1933 年证券法下注册，且不会向美国投资者提供。此次配售所得预计将支持公司的未来业务发展。免责声明：本新闻简报由公共技术公司（PUBT）使用生成性人工智能创建。虽然 PUBT 努力提供准确及时的信息，但此 AI 生成的内容仅供参考，不应被解读为财务、投资或法律建议。上海康耐特光学有限公司于 2026 年 1 月 26 日通过香港证券交易所（HKex）运营的发行人信息服务（IIS）发布了用于生成本新闻简报的原始内容（参考编号：HKEX-EPS-20260127-12001695），并对此信息承担全部责任。© 版权 2026 - 公共技术公司（PUBT）

### Related Stocks

- [02276.HK - 康耐特光学](https://longbridge.com/zh-CN/quote/02276.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Shanghai Conant Optical Raises Share Capital with Issue of (Number) New Shares at (Price) Each | Shanghai Conant Optical Co. Ltd. has announced a change in its issued H shares through a Next Day Disclosure Return file | [Link](https://longbridge.com/zh-CN/news/274664283.md) |
| AI music is here to stay — and it could offer a lifeline to struggling record companies | AI music is here to stay — and it could offer a lifeline to struggling record companies | [Link](https://longbridge.com/zh-CN/news/276433797.md) |
| 20:30 ETPhilanthropic Partnership Backs Country-Led Research to Guide the Use of AI in Health | The Gates Foundation, Novo Nordisk Foundation, and Wellcome have announced a joint investment of $60 million to support  | [Link](https://longbridge.com/zh-CN/news/276399782.md) |
| 14:25 ETiMused Marks First Official Platform Song Release With "The Bag," Written by CLEO-P Using Arya Starr's Musical DNA as the Muse Source | iMused, an ethical AI music platform, has launched its first official song, "The Bag," written by CLEO-P using Arya Star | [Link](https://longbridge.com/zh-CN/news/276370780.md) |
| 14:13 ETMediKarma Validates "Agentic AI" in Clinical Intervention Study: Demonstrates 50% A1C Reduction; Proves Friction-Free Alternative to ChatGPT | MediKarma announced successful results from a 120-day clinical intervention study with Dallas Endocrinology, validating  | [Link](https://longbridge.com/zh-CN/news/276159549.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。
